Nico J.M. van Beveren

3.3k total citations
41 papers, 1.4k citations indexed

About

Nico J.M. van Beveren is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Molecular Biology. According to data from OpenAlex, Nico J.M. van Beveren has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 15 papers in Biological Psychiatry and 11 papers in Molecular Biology. Recurrent topics in Nico J.M. van Beveren's work include Schizophrenia research and treatment (15 papers), Tryptophan and brain disorders (15 papers) and Diet and metabolism studies (8 papers). Nico J.M. van Beveren is often cited by papers focused on Schizophrenia research and treatment (15 papers), Tryptophan and brain disorders (15 papers) and Diet and metabolism studies (8 papers). Nico J.M. van Beveren collaborates with scholars based in Netherlands, United Kingdom and United States. Nico J.M. van Beveren's co-authors include Lieuwe de Haan, Nuray Çakici, Iris E. Sommer, Brenda W.J.H. Penninx, Maju Mathew Koola, Hemmo A. Drexhage, Arjen L. Sutterland, Sabine Bahn, F. Markus Leweke and Paul C. Guest and has published in prestigious journals such as PLoS ONE, Psychological Medicine and Neuropsychopharmacology.

In The Last Decade

Nico J.M. van Beveren

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nico J.M. van Beveren Netherlands	22	657	495	292	242	169	41	1.4k
Lucas B. Rizzo Brazil	24	716 1.1×	764 1.5×	263 0.9×	283 1.2×	134 0.8×	40	1.8k
Vanessa Ota Brazil	22	551 0.8×	452 0.9×	389 1.3×	292 1.2×	263 1.6×	81	1.4k
Mandana Ashrafi Iran	22	866 1.3×	761 1.5×	286 1.0×	369 1.5×	119 0.7×	31	2.2k
Sigrun Hope Norway	23	727 1.1×	605 1.2×	295 1.0×	321 1.3×	212 1.3×	45	1.5k
Yingjun Zheng China	22	312 0.5×	381 0.8×	342 1.2×	136 0.6×	159 0.9×	79	1.6k
Karina S. MacDowell Spain	23	814 1.2×	336 0.7×	278 1.0×	371 1.5×	57 0.3×	61	1.4k
Alain Gendron Canada	17	725 1.1×	610 1.2×	185 0.6×	357 1.5×	64 0.4×	34	1.5k
Francesco Giorlando Australia	12	551 0.8×	751 1.5×	114 0.4×	145 0.6×	142 0.8×	14	1.4k

Countries citing papers authored by Nico J.M. van Beveren

Since Specialization

Citations

This map shows the geographic impact of Nico J.M. van Beveren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nico J.M. van Beveren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nico J.M. van Beveren more than expected).

Fields of papers citing papers by Nico J.M. van Beveren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nico J.M. van Beveren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nico J.M. van Beveren. The network helps show where Nico J.M. van Beveren may publish in the future.

Co-authorship network of co-authors of Nico J.M. van Beveren

This figure shows the co-authorship network connecting the top 25 collaborators of Nico J.M. van Beveren. A scholar is included among the top collaborators of Nico J.M. van Beveren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nico J.M. van Beveren. Nico J.M. van Beveren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soni, Shubham, et al.. (2025). Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia. Psychiatry Research. 345. 116379–116379. 1 indexed citations

Gangadin, Shiral S., et al.. (2024). Immune Dysfunction in Schizophrenia Spectrum Disorders. Annual Review of Clinical Psychology. 20(1). 229–257. 12 indexed citations

Mané-Damas, Marina, Jo Stevens, Kishore S. Malyavantham, et al.. (2021). The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens. Schizophrenia Research. 228. 462–471. 8 indexed citations

Kaiser, Fabian, Hanna IJspeert, P. Martin van Hagen, et al.. (2021). Activated PI3Kδ syndrome, an immunodeficiency disorder, leads to sensorimotor deficits recapitulated in a murine model. Brain Behavior & Immunity - Health. 18. 100377–100377. 9 indexed citations

Çakici, Nuray, Arjen L. Sutterland, Brenda W.J.H. Penninx, et al.. (2020). Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis. Brain Behavior and Immunity. 88. 547–558. 122 indexed citations

Sommer, Iris E., Shiral S. Gangadin, Renske E. Blom, et al.. (2020). Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design. Trials. 21(1). 492–492. 7 indexed citations

Çakici, Nuray, et al.. (2019). An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis. Psychological Medicine. 49(14). 2307–2319. 159 indexed citations

Canuti, Marta, Stephen L. Buka, Seyed Mohammad Jazaeri Farsani, et al.. (2015). Reduced maternal levels of common viruses during pregnancy predict offspring psychosis: Potential role of enhanced maternal immune activity?. Schizophrenia Research. 166(1-3). 248–254. 12 indexed citations

Beveren, Nico J.M. van, Emanuel Schwarz, Richard Noll, et al.. (2014). Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia. Translational Psychiatry. 4(8). e430–e430. 30 indexed citations

10.

Marcelis, Machteld, Sanne Peeters, Marcel M. Verbeek, et al.. (2013). Replicated Evidence of Absence of Association between Serum S100B and (Risk of) Psychotic Disorder. PLoS ONE. 8(12). e82535–e82535. 10 indexed citations

11.

Ramsey, Jordan M., Emanuel Schwarz, Paul C. Guest, et al.. (2013). Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients. PLoS ONE. 8(11). e78729–e78729. 51 indexed citations

12.

Beveren, Nico J.M. van, Lianne C. Krab, Sigrid Swagemakers, et al.. (2012). Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome. PLoS ONE. 7(3). e33473–e33473. 26 indexed citations

13.

Beveren, Nico J.M. van, Lianne C. Krab, Sigrid Swagemakers, et al.. (2012). Correction: Functional Gene-Expression Analysis Shows Involvement of Schizophrenia-Relevant Pathways in Patients with 22q11 Deletion Syndrome. PLoS ONE. 7(4). 5 indexed citations

14.

Beveren, Nico J.M. van, Gabriëlle H.S. Buitendijk, Sigrid M. A. Swagemakers, et al.. (2012). Marked Reduction of AKT1 Expression and Deregulation of AKT1-Associated Pathways in Peripheral Blood Mononuclear Cells of Schizophrenia Patients. PLoS ONE. 7(2). e32618–e32618. 53 indexed citations

15.

Weigelt, Karin, Lívia A. Carvalho, Annemarie Wijkhuijs, et al.. (2011). TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behavior and Immunity. 25(6). 1162–1169. 57 indexed citations

16.

Dekker, Natashe Lemos, et al.. (2011). Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychological Medicine. 42(4). 705–716. 29 indexed citations

17.

Winkel, Ruud van, et al.. (2011). AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder. Neuropsychopharmacology. 36(12). 2529–2537. 61 indexed citations

18.

Hempel, Roelie, J.H.M. Tulen, Nico J.M. van Beveren, et al.. (2010). Diurnal cortisol patterns of young male patients with schizophrenia. Psychiatry and Clinical Neurosciences. 64(5). 548–554. 35 indexed citations

19.

Hempel, Roelie, J.H.M. Tulen, Nico J.M. van Beveren, Paul Mulder, & Michiel W. Hengeveld. (2007). Subjective and physiological responses to emotion-eliciting pictures in male schizophrenic patients. International Journal of Psychophysiology. 64(2). 174–183. 32 indexed citations

20.

Beveren, Nico J.M. van, et al.. (2006). Schizophrenia-associated neural growth factors in peripheral blood. A review. European Neuropsychopharmacology. 16(7). 469–480. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucas B. Rizzo Breakdown of academic impact, for papers by Vanessa Ota Breakdown of academic impact, for papers by Mandana Ashrafi Breakdown of academic impact, for papers by Sigrun Hope Breakdown of academic impact, for papers by Yingjun Zheng Breakdown of academic impact, for papers by Karina S. MacDowell Breakdown of academic impact, for papers by Alain Gendron Breakdown of academic impact, for papers by Francesco Giorlando